Altogether, our data validate the functional role of AXL in the pathogenesis of ZIKV at the maternal-fetal interface, acting as a crucial receptor for ZIKV entry in DSCs, and suggest that targeting AXL at an early stage of the infection through the blockade of ligand binding is efficient to drastically reduce ZIKV infection during pregnancy. Here, AXL is linked to Zika virus infectious disease.